SCHEMBL5453372

SCHEMBL5453372

CCc1cccc2nc(N)n(CCN(C)C(=O)c3ccccc3)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 4/20 0.41
CXCR3 P49682 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
POLB P06746 1/20 0.38
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5468452 0.94 TLR8 (0.45) TLR8CXCR3SMN1; SMN2NPC1RAB9A
SCHEMBL5463737 0.87 PRMT5 (0.47) TLR8CXCR3SMN1; SMN2NPC1RAB9A
SCHEMBL5468418 0.82 POLB (0.55) TLR8CXCR3SMN1; SMN2NPC1RAB9A
SCHEMBL5482661 0.81 CXCR3 (0.53) TLR8CXCR3SMN1; SMN2NPC1RAB9A
SCHEMBL5480685 0.80 TLR8 (0.48) TLR8CXCR3LMNAPOLBCYP1A2
SCHEMBL5454917 0.78 TLR8 (0.43) TLR8LMNAPOLBCYP1A2CYP2D6
SCHEMBL14470744 0.78 CXCR3 (0.41) TLR8CXCR3SMN1; SMN2NPC1RAB9A
SCHEMBL5454116 0.76 POLB (0.58) TLR8POLBCYP1A2CYP2D6HTT
SCHEMBL5465854 0.74 TLR8 (0.66) TLR8POLBCYP1A2CYP2D6HTT
SCHEMBL5451191 0.73 CYP1A2 (0.56) TLR8LMNAPOLBCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 TLR8 3837/4885CXCR3 4743/4885SMN1; SMN2 824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.